APOL1-IN-1 free base

APOL1-IN-1 is a apolipoprotein L1 (APOL1) inhibitor extracted from patent WO2020131807A1 compound 87.

For research use only. Not for human or veterinary use.

Target Apolipoprotein

Research area Metabolic Disease

Purity >98% Stock Inquire

Data Sheet SDS COA

APOL1-IN-1 structure

CAS No.: 2446817-72-5

Download structure (.mol)

Pack sizes & pricing

Size	Price	SKU	Stock
25 mg	USD 620.00	BP-02021-25mg	In stock	Get quote
50 mg	USD 850.00	BP-02021-50mg	In stock	Get quote
100 mg	USD 1,180.00	BP-02021-100mg	In stock	Get quote
250 mg	USD 1,720.00	BP-02021-250mg	In stock	Get quote
500 mg	Inquire	BP-02021-500mg	In stock	Inquire
1 g	Inquire	BP-02021-1g	In stock	Inquire

Need another size or custom synthesis? Request a quote.

Description

APOL1-IN-1 is a apolipoprotein L1 (APOL1) inhibitor extracted from patent WO2020131807A1 compound 87. APOL1-IN-1 can be used for the research of focal segmental glomerulosclerosis (FSGS) and non-diabetic kidney disease (NDKD).

Identifiers

SMILES: O[C@H](CNC1=O)[C@@H]1NC(CCC2=C(C3=CC=C(C=C3)F)NC4=CC=CC=C42)=O
InChIKey: CNYZYDUBGMRAFP-XLIONFOSSA-N

Specifications

MW (average): 381.4002
Formula: C₂₁H₂₀FN₃O₃
CAS No.: 2446817-72-5
Physical state: Solid
Color: white to off-white
Shipping: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage: Powder -20°C, 3 years ; In solvent -20°C, 1 month

Solubility

Soluble in DMSO : 125 mg/mL

Documents

References

[1]. Brodney M, et, al. Inhibitors of apol1 and methods of using same. WO2020131807A1.

Same target

Search Apolipoprotein

Same research area

Search Metabolic Disease